Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013 Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012 Abstract | Paper+ | Slides
+ Papers available to view from 8th April 2013 to 7th May 2013.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.